ABSTRACT The vasoactive intestinal polypeptide was present in synaptosomal (nerve ending) preparations from cerebral cortex, hypothalamus, and striatum of rat brain in higher concentrations than in these tissues as a whole. The total content and relative specific activity of the peptide increased with progressive purification of the synaptosomal fractions and generally followed the distribution of known synaptosomal constituents-dopamine, norepinephrine, and lactate dehydrogenase (L-lactate:NAD+ oxidoreductase, EC 1.1.1.27). The peptide was also released from synaptosomal pellets with increased K+ concentration, and this release was Ca2+-dependent. The findings suggest a role for vasoactive intestinal polypeptide as a transmitter or modulator of synaptic function. Vasoactive intestinal polypeptide (VIP), a 28-residue peptide that is structurally related to secretin and glucagon, has been isolated from porcine duodenum (1, 2). Until recently, its normal presence was thought to be limited to the gastrointestinal tract, but the discovery of high levels of VIP immunoreactivity in neural cell lines and in mammalian brain (3-5) has established its presence in the nervous system as well. VIP thus joins a number of other polypeptides-including somatostatin, substance P. neurotensin, and the enkaphalins-that have been shown to occur both in gut and in brain (6) (7) (8) (9) (10) (11) .
MATERIALS AND METHODS VIP for iodination and for standard solutions in the radioimmunoassay was the natural porcine peptide (2) , prepared in the laboratory of V. Mutt, Karolinska Institute, Stockholm. 125I-The costs of publication of this article were defrayed in part by the payment of page charges from funds made available to support the research which is the subject of the article. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Preparation of Synaptosomes. Male rats (Sprague-Dawley, 350 g) were killed by decapitation. Brains were removed, and hypothalamic, striatal, and cortical areas were dissected according to the method of Glowinsky and Iversen (13) . All procedures were carried out at 40. Brain areas were homogenized in 10 volumes of cold 0.32 M sucrose containing pargyline (0.1 mM) in a glass homogenizer with a Teflon pestle (Kontes) for 30 sec at 600 rpm. Subsequent centrifugations, collection, and designation of fractions were essentially as described by Whittaker (14) and DeRobertis (15) , with the following modification. The nuclear fraction (P1) was washed once and recentrifuged at 1000 X g for 10 min. The combined supernatants were centrifigued at 12,000 X g for 20 min; the pellet was resuspended once in the original volume of 0.32 M sucrose and recentrifuged as above. The new pellet, P2, was subfractionated by centrifugation in sucrose gradients.
For centrifugation on discontinuous density gradients, the P2 pellet was resuspended in half the original volume of 0.32 M sucrose, and 1 ml of this suspension was layered on a discontinuous density gradient consisting of equal amounts of 0.8 M and 1.2 M sucrose and centrifuged at 51,000 X g for 2 hr (rotor SW39, Beckman model L ultracentrifuge). Six fractions were collected by aspiration: (i) 0.5-0.6 ml of 0.32 M sucrose; (Hi) 1 ml, at the interface with 0.8 M sucrose, containing white fluffy material (myelin); (iii) 1 ml of 0.8 M sucrose; (iv) 1 (18) as follows. Triton X-100 was added to each sample to a final concentration of 0.05%, to release the occluded activity. Aliquots of the sample were then added to a reaction mixture consisting of 1 mM Na pyruvate, 0.1 mM NADH, and 0.05 M Na phosphate buffer (pH 7.4) to a volume of 2 ml; the oxidation of NADH was followed with a recording spectrophotometer (Gilson) for 5 min, and the enzyme activity in the sample was calculated from the change in A at 340 nm; 1 unit of enzyme equals 1 umol of NADH oxidized per min. NE and dopamine were determined spectrophotometrically after extraction with HCI04 (0.4 M final concentration), purification with alumina, and oxidation according to Chang (19) .
When [3H]NE was used to label noradrenergic neurones, the 3H present in the fractions was determined directly in an aliquot (50 Ml) of sucrose by adding 10 ml of Aquasol (New England Nuclear) and assaying for radioactivity with a liquid scintillation spectrometer. Earlier experiments had shown that under our experimental conditions most of the radioactivity (>85%)
represented unchanged [3H]NE. VIP was measured by a sensitive radioimmunoassay as described (20) , with the following modifications: a high-titer (>1:150,000), specific antiserum was produced by immunization with VIP-bovine serum albumin conjugate, and 125I-labeled VIP was prepared by the lactoperoxidase method. The lower limit of sensitivity of the assay was 20 pg. The assay showed negligible crossreactivity with these peptides: secretin, glucagon, cholecystokinin-pancreozymin, porcine pancreatic polypeptide, substance P, somatostatin, a-endorphin [fl-lipotropin-(61-76)], neurotensin, Leu-enkephalin, Met-enkephalin,, bradykinin, and angiotensin II.
Samples for electron microscopic examination of synaptosomal fractions were prepared as described (21) .
Statistical analysis was performed by Student's t test, using paired or unpaired comparisons. P values less than 0.05 were considered significant.
RESULTS

VIP in subcellular fractions
The peptide levels were particularly high in homogenates from cerebral cortex-(26.4 ng/g of tissue), being twice as high as in hypothalamus and greater than in striatum (Table 1) . Differential centrifugation of these homogenates yielded the classical subcellular fractions (14)-i.e., cell nuclei and debris (Pi); microsomes (S2); and crude synaptosomes, also containing mitochondria (P2). The P2 fractions characteristically contained the bulk of the proteins, the mitochondrial enzyme SDH, and the neurotransmitter NE (measured in hypothalamic preparations) or dopamine (measured in striatal preparations) (Fig. 1 ). When examined with the electron microscope after fixation with glutaraldehyde, the P2 pellets showed several synaptosomal profiles, some containing synaptic vesicles and vacuoles (Fig.  2) .
In each of the three brain areas examined, the concentration of VIP was highest in the P2 fraction (P < 0.01) (Table 1, Fig.  1 ). The distribution of VIP, relative to its total recovered content, was similarly highest in the crude synaptosomal fractions. Thus, the percentages of VIP in P2 fractions were 54.4 for hypothalamus, 61.8 for striatum, and 50.9 for cerebral cortex ( Table 2 ). The relative specific activity of VIP (i.e., its percentage content relative to that of protein) was also highest in the P2 fraction in each instance.
Cell Biology: Giachetti et al. 3426 Cell Biology: Giachetti et al. The sum of VIP levels in the three subcellular fractions consistently exceeded the peptide content in the original homogenate (Table 1) . Further purification of synaptosomal fractions On subfractionation of the crude synaptosomal fractions by centrifugation in discontinuous sucrose gradients (Table 3) , VIP immunoreactivity was recovered mainly in the purified synaptosomes which were also richest in dopamine and in proteins; the purified mitochondrial pellet contained most of the SDH activity.
With continuous sucrose-gradient centrifugation (Fig. 3) , mitochondria (SDH) sedimented in a band of heavy sucrose (fractions [3] [4] [5] [6] , distinct from the band (fractions 6-10) containing the bulk of LDH activity, an enzyme considered to be a synaptosomal marker (18) . The distribution of VIP (fractions [6] [7] [8] [9] [10] [11] [12] followed closely that of LDH. The highest specific activity of VIP (1.81) occurred in fraction 11, whereas that of LDH (1.71) was in fraction 9. In the experiment shown in Fig.  3 , the hypothalamic preparation had been incubated in vitro with [3H]NE before the isolation of synaptosomes. The bulk of the labeled neurotransmitter was found in the same band of sucrose (fractions 6-12) containing the major portions of LDH and VIP. The peak specific activity of [3HJNE (1.84) was in fraction 10. Due to slight variations in the collection of fractions, the results of multiple experiments could not be combined, but six experiments with striatal and hypothalamic tissues gave essentially the same distribution as shown. We also verified the integrity of the synaptosomal preparation by showing that the [3H]NE uptake was via an active process: incubation on ice was followed by little incorporation of radioactivity in the major synaptosomal peak.
Release of VIP from synaptosomes Raising the K+ concentration in the incubation medium from 5.9 to 55 mM in the presence of Ca2+ evoked an increase in VIP concentration in the medium over a SO-min period, from 91 ± 8 to 173 h 18 pg/ml (15 determinations, P < 0.0005). Omission of Ca2+ from the medium abolished the apparent release of the peptide from cortical synaptosomes under the same conditions (six determinations, p < 0.0025). The absence of Ca2+ itself was associated with a fall in VIP concentration from 91 4 8 to 79
:19 pg/ml, but the difference was not significant. DISCUSSION The abundance of VIP-like immunoreactivity in the brain areas examined, especially in cerebral cortex, confirms earlier studies on the distribution of this peptide in dog brain (3) and is in agreement with immunohistochemical observation in rats (12) . In this respect, the regional distribution of VIP differs from that of most other brain peptides-e.g., substance P and neuro- tensin-which are found in low concentrations in the cortex and resembles that of gastrin-like or cholecystokinin-like immunoreactivity (22, 23) .
Our experiments show that isolated nerve terminals (synaptosomes) from cerebral cortex, hypothalamus, and striatum of rat brain are enriched in VIP. This enrichment was evident in the crude synaptosomal fractions (P2 pellets) and became more pronounced with their progressive purification by centrifugation on discontinuous or continuous sucrose gradients. In these fractions, the highest concentrations (and relative specific activity) of the peptide coincided closely with those of NE and of LDH, a synaptosomal enzyme. The increase in total VIP immunoreactivity after fractionation of the homogenates is at present unexplained, though a similar finding was reported for brain neurotensin (24) .
The finding that VIP is concentrated in synaptosomal preparations agrees with immunocytochemical localization of the peptide, done with the same antibody, in nerve terminals of the neocortex, neostriatum, central amygdaloid nucleus, and suprachiasmatic, medial preoptic, and anterior hypothalamic nuclei (12) .
The demonstrated K+-evoked release of VIP from synaptosomes and the prevention of this release with omission of Ca2+ suggest that the peptide may be released from nerve terminals by physiologic-e.g., depolarizing-stimuli. Similar observations have been made for NE (25) and more recently for substance P (26) .
Our findings that isolated nerve terminals are enriched in VIP and that they may release it with increased K+ concentration in the presence of Ca2+ lend support to the possibility that VIP may have a physiologic role in synaptic function, either as a transmitter or as a modulator of the actions of other transmitters (27) . The selective distribution of the peptide in cerebral cortex, especially in layers II-IV of the neocortex, within association neurons (12) , suggests a special role in integrative activity. The significance of the prevalence of VIP in hypothalamic and striatal nerve terminals is undetermined. Because VIP is a potent vasodilator, is located in cerebrovascular nerves (28) , and augments cerebral blood flow in intact animals (unpublished observations), the peptide may serve as a mediator of cerebral vasodilation. The possibility that VIP, like other brain peptides, may also influence neuronal function without affecting synaptic transmission per se (29, 30) 
